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Abstract. Charcot-Marie-Tooth disease type IB (CMT 1B) is caused by mutations in the gene 
coding for peripheral myelin protein zero (MPZ, P0) that plays a fundamental role in adhesion 
and compaction of peripheral myelin. Here we report a Costa Rican family with a hereditary 
peripheral neuropathy due to a novel Tyr145Ser MPZ mutation. Four family members were 
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heterozygously affected; two siblings of two heterozygous carriers were homozygous for this 
mutation. On neurological examination the heterozygous parents and their homozygous children 
both showed distal sensory deficits. The mother and the siblings displayed impaired deep tendon 
reflexes and mild sensory ataxia. The homozygous individuals were more severely affected with 
an earlier age of onset, distal motor weakness, and pupillary abnormalities. Electrophysiological 
studies revealed both signs of demyelination and axonal nerve degeneration. The sural nerve 
biopsy of one sibling showed thinly myelinated nerve fibers, onion bulb formation, and clusters 
of regenerating fibers. On electron microscopy axonal degeneration and decompaction of inner 
myelin layers were found. This Costa Rican family shows phenotypic variability depending on 
the homozygous or heterozygous state of the Tyr145Ser mutation carriers. 
Keywords MPZ, PO - CMT1B HMSN1B - Charcot-Marie-Tooth disease 
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Introduction 
Hereditary motor and sensory neuropathies (HMSN) are a clinically and genetically 
heterogeneous group of disorders of the peripheral nervous system. The most-common form is 
HMSN type 1, synonymous to Charcot-Marie-Tooth (CMT) disease type 1. Although the clinical 
course is often relatively mild, inter- and intrafamilial phenotypic variations are observed. 
Asymptomatic mutation carriers, as well as patients showing severe muscular weakness and 
atrophy, have been reported. One diagnostic hallmark of the demyelinating CMT type 1 is a 
reduced nerve conduction velocity (NCV); patients with the axonal or CMT type 2 show almost 
normal NCVs [1]. Mutations in at least four different genes can cause CMT type 1: the 
peripheral myelin protein 22 gene (PMP22), the myelin protein zero gene (MPZ/P0), the 
connexin 32 (Cx32/GJB 1) gene, and the early growth response 2 gene (EGR2) [2]. The vast 
majority of patients carry a 1.4-Mb duplication in chromosome 17p11.2-12, including the 
PMP22 gene [3, 4]. Less frequently, mutations in PO are observed as a cause of CMT type 1B 
disease (CMT1B) [Online Mendelian Inheritance in Man (0M1M), 
http://www.ncbi.nlm.nih.gov/omim (MIM 118200)] [5]. 
PO is the major structural protein of peripheral myelin, an integral membrane glycoprotein (28 
kilodaltons) that is expressed exclusively in the Schwann cells. It is composed of an extracellular 
domain (immunoglobulin related), a transmembrane domain, and a basic intracellular domain. It 
contributes to the compaction of the intraperiod and major dense line [6, 7]. The gene is located 
on chromosome 1q22-q23 and is composed of six coding exons. Both extracellular and 
intracellular domains are important for adhesion and myelination [8, 9]. Mutations in PO may 
affect the ability to form homotetramers or to mediate homophilic adhesion, processes that are 
fundamental for the compaction of myelin sheaths in peripheral nerves [10]. Morphological 
studies of patients with CMT 1B indicate signs of demyelination, such as thinly myelinated 
nerve fibers, impaired Schwann cell proliferation, tomacula, and uncompacted myelin layers. In 
addition to the pathological changes of the myelin sheath, axonal degeneration may be observed 
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It is difficult to establish a correlation between genotype and phenotype of P0-related peripheral 
neuropathies [2]. Two severe, early onset forms of peripheral neuropathies, the Dejerine-Sottas 
syndrome and congenital hypomyelinating neuropathy, demonstrate the wide phenotypic 
variation of patients carrying PO mutations, depending on the codon position and the nature of 
the substitution [12]. Additionally the Roussy-Levy syndrome could be associated with a specific 
mutation in the extracellular domain of PO [13]. 
Moreover, the phenotypic variability of P0 mutation carriers comprises axonally pronounced 
peripheral neuropathies (CMT2), which has been shown for a Thr124Met mutation [14, 15]. 
Carriers of this Thr124Met mutation also show Argyll Robertson-like pupils, and deafness and 
dysphagia frequently accompany the disease. Here we present CMT patients of a Costa Rican 
family who carry a previously undescribed Tyr145Ser mutation of the PO gene in the 
heterozygous and homozygous state. The severity of the peripheral neuropathy corresponds to 
the genetic state of this particular PO mutation. 
Materials and methods 
A Costa Rican family of four generations with six living CMT patients was investigated. DNA 
from the family members was obtained from peripheral blood, following standard methods. 
All six coding PO exons were amplified for the following individuals: III:1, III:2,111:3, 
IV:1, and IV:2, using primer sequences already published [16]. Sequencing was 
performed in both directions, using the same primers and BigDye Terminator version 3.0 
(Applied Biosystems) with an ABI 3100 DNA Sequencer (Applied Biosystems), and analyzed 
with the Sequence Analyzer (Applied Biosystems) and Seqman II (DNAstar) software. For all 
these procedures, informed consent from the family members was obtained. 
Family history was collected, in order to find a genealogical relationship between individuals 
III:4 and III:5, and to document the phenotype of the family ancestors. To evaluate this 
relationship experimentally, microsatellite markers close to PO were investigated in the family 
members. Specific printers for repeats in loci D1S2705 and D1S2771 were used for polymerase 
chain reaction (PCR), and the products were analyzed with an ABI 3100 Sequencer and 
Genescan and Genotyper software (Applied Biosystems). 
A physical examination was performed in subjects 111:4, III:5, IV:1, and IV:2. Motor weakness 
and muscle wasting, sensory perception for light touch, pain, vibration, and joint position, deep 
tendon reflexes, and skeletal deformities were assessed. The cranial nerve status was also 
examined. Standard electrophysiological tests [17] were performed in the median, ulnar, 
peroneal, tibial, and sural nerves in all subjects. A sural nerve biopsy was taken from individual 
IV:1 and processed for light and electron microscopy according to standard techniques. The sural 
nerve was fixed with glutaraldehyde and embedded in epoxy resin. For light microscopy I-gm 
sections were stained with methylene blue. For electron microscopy, 80-run ultrathin sections 
were stained with lead citrate and uranyl acetate. Morphometric parameters were analyzed by 
light (x200 enlargement) and electron microscopy (between x1,600 and x16,700 enlargement). 
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Results 
The hereditary peripheral neuropathy in family CR-CMT2 follows an autosomal dominant 
pattern of inheritance (Fig. 1). The family history of subjects 111:4 and 111:5, indicated that 
individuals I:1, II:1, II:4, and 11:5 possibly also presented the disease. 
Fig. 1. Pedigree of the Costa Rican family CR-CMT2 with autosomal dominant Charcot-Marie-Tooth 
disease. Phenotypes of members of the first and second generation are assumed according to 
testimonies of descendents. Individuals IV:1 (+) and IV:2 (+) are homozygous for a mutation in MPZ and 
presented a more-severe phenotype than the heterozygous members 
No mutations were found in the PO exons 1, 2 and 4-6 in any family member. In contrast, in the 
PO exon 3 an A —W transversion (c.434A>C) was found, resulting in a novel missense mutation 
Tyr145Ser. Individuals 	 111:4, 111:5, and III:6 are heterozygous for this mutation, whereas 
individuals IV:1 and IV:2 (children of two heterozygous patients) are homozygous carriers 
(Fig. 2). Healthy individuals of the family do not carry the mutation. This transversion has not 
been reported previously, either as a polymorphism or as a pathogenic mutation (Inherited 
Peripheral Neuropathies Mutation Database, http://molgen-www.uia.ac.be/cmtMutations/). In 
addition, 50 healthy non-related controls were screened who did not carry this Tyr145Ser 
mutation. 
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Fig. 2. DNA sequence of the axon 3 of MPZ in a healthy control, a heterozygous (111:4) and a 
homozygous (IV:2) carrier of the Tyr145Ser mutation. The nucleotide exchange (A—}C) results in an 
amino acid change in codon 145 (Tyr-+Ser) 
Although it was not possible to establish a genealogical relationship between the paternal and the 
maternal branches, analysis with polymorphic markers showed that in both branches the mutated 
allele is related to a 148-bp PCR product of marker D1S2705 and a 250-bp PCR product of 
marker D1S2771. 
Upon clinical examination, individuals III:1, III:4, III:5, and III:6 had a mild peripheral 
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neuropathy characterized by a late age of onset (after 51 years), whereas individuals IV:1 and 
IV:2 had an earlier age of onset (38 and 39 years, respectively) and a more-severe neuropathy. 
The parents III:4 and III:5, heterozygous for the Tyr145Ser mutation, as well as their children 
IV:1 and IV:2, homozygous for the Tyr145Ser mutation, were studied in more detail. The father 
(patient 111:4) did not report a serious impairment of his daily activities at 65 years of age. 
Disease duration ranged from 2 to 4 years in the siblings, and was 11 years in the mother (III:5); 
the father's (III:4) disease duration could not be defined exactly. All mutation carriers showed 
distal sensory deficits in a stocking-glove pattern for light touch and pin perception, which were 
more pronounced in the lower limbs. Vibration perception in the feet was severely impaired in 
all patients. Individuals 
	 IV:1, and IV:2 showed mild sensory ataxia. Motor weakness and 
wasting of distal muscles were present only in the children IV:1 and IV:2. Deep tendon reflexes 
of the lower limbs (ankle jerk, patellar and adductor deep tendon reflexes) were reduced or 
absent in the mother and children, whereas the father's patellar deep tendon reflex was still 
preserved. Pupillary abnormalities with mydriasis and no reaction to light were also only present 
in the siblings IV:l. and IV:2. The daughter IV:1 reported progressive deafness; she presented 
mild hypacusis of both ears. The electrophysiological studies revealed reduced or absent 
compound muscle action potentials and normal or reduced motor NCVs in the lower limbs. 
Sensory nerve action potentials of the sural nerve could be detected only in the daughter, with a 
reduced amplitude and a prolonged sensory NCV. Electromyographic studies of the anterior 
tibial muscle were compatible with either active or chronic denervation as a sign of axonal 
lesion. An increased number of polyphasic motor unit potentials (MUPs) and increased 
amplitudes of the MUPs were found. A pattern of reduced recruitment activity to full effort was 
also observed. The diagnosis was further confirmed by a sural nerve biopsy of the daughter. 
Analysis of the semithin sections revealed a moderate decrease in myelinated nerve fiber density. 
Clusters of mainly four to six thinly myelinated nerve fibers were observed, showing 
regenerating axonal sprouts. Additionally, several thinly myelinated axons could be found, often 
surrounded by proliferating Schwann cells forming onion bulbs. The ultrastructural examination 
showed peri- and intra-axonal vacuoles as a sign of axonal degeneration. Clusters of 
unmyelinated axons in bands of Biingner indicated wallerian degeneration. Furthermore, signs of 
myelin degeneration, with decompacted lamellae of the myelin layers and abnormal myelin 
thickening forming loops and folds, were detected. These findings confirmed the 
electrophysiological findings of both axo 
http://www.springerlink.corn/app/home/content.asp?wasp=n2v6e330xgOwnw50eaak&ref... 20/08/2003 
